Memphis, TN, United States
Rx Pak Division of McKesson Corporation recalls
1 recall recorded since 2018, most recently on 16 January 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 16 January 2019
- Terminated
- 2 December 2020
- Reason
- Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
- Distribution
- Product was distributed to 5 major distributors who may have further distributed the product throughout the United States.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1007-2019
- Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.